Keywords: PCPs; personal care products; TMICS; Taiwan Mother Infant Cohort Study; ICCs; intraclass correlation coefficients; MMP; mono-methyl phthalate; MEP; mono-ethyl phthalate; MnBP; mono-n-butyl phthalate; MiBP; mono-isobutyl phthalate; MiNP; mono-isononyl phth
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: OPG; optic pathway glioma; NF1; neurofibromatosis type 1; SEER Program; surveillance, epidemiology, and end results; US; United States; IR; incidence rate; IRR; age-adjusted incidence rate ratio; CIs; confidence intervals; OR; odds ratio; Optic pathway gl
Keywords: penile neoplasms; neoplasm recurrence; local; organ sparing treatments; carcinoma; squamous cell; mortality; CIS; carcinoma in situ; LRFS; local recurrence-free survival; PSS; penile sparing surgery;
Keywords: Ang; angiopoietin; Tie-2; tyrosine kinase with immunoglobulin-like loop epidermal growth factor domain 2; Ang-2/Ang-1; Angiopoietin-2/Angiopoietin-1 ratio; Ang-1/Tie-2; Angiopoietin-1/Tie-2 ratio; ICAM-1; intercellular adhesion molecule-1; VCAM-1; vascula
Keywords: CIs; confidence intervals; MDA; mass drug administration; MoHP; Ministry of Health and Population; NSCP; National Schistosomiasis Control Programme; WHO; World Health Organization; S. haematobium; Urine filtration; Mapping; Elimination; Egypt;
Keywords: Bladder carcinoma; Cystectomy; Sexual function preserving; Prostate sparing; Neobladder; BC; bladder cancer; BCG; bacillus Calmette-Guérin; CSM; Cancer specific mortality; CSS; Cancer specific survival; CIS; carcinoma in situ; CIC; clean intermittent cat
Keywords: TCS; Tobacco Control Scale; EPHR; European Perinatal Health Report; rsp; Spearman rank-correlation coefficients; 95%CI; 95% confidence intervals; SHS; secondhand smoke; CIs; confidence intervals; HDI; Human Development Index; GDP; gross domestic product;
Keywords: CF; cystic fibrosis; FEV1; predicted percentage of forced expiratory volume in 1Â s; HRQoL; health-related quality of life; CFQ; Cystic Fibrosis Questionnaire; CIS; Checklist Individual Strength; HAES; Habitual Activity Estimation Scale; BMI; body mass in
Keywords: ureter; kidney; carcinoma in situ; urothelium; prognosis; BCG; bacillus Calmette-Guérin; B-CIS; bladder CIS; c-CIS; concomitant CIS; CIS; carcinoma in situ; CSS; cancer specific survival; p-CIS; pure/primary CIS; RNU; radical nephroureterectomy; UTUC; up
Keywords: AA; Aquatic Acidification; AE; Aquatic Ecotoxicity; AEU; Aquatic Eutrophication; C; Carcinogen; CdTe; Cadmium-Telluride; CIS; Copper-Indium-Selenide; CUT; cut-off value; EPBT; Energy Payback Time; GA; Genetic Algorithms; GW; Global Warming; IR; Ionizing R
Keywords: aHR; adjusted HR; BRCA2; breast cancer 2, early onset; CIs; confidence intervals; DFS; disease-free survival; ENCODE; encyclopedia of DNA Elements; ERCC1; excision repair cross-complementing group 1; ERG; V-ets avian erythroblastosis virus E26 oncogene re
Keywords: AD; axial diffusivity; CIS; Canadian Interuniversity Sports; CR; corona radiata; dMRI; diffusion magnetic resonance imaging; EC; external capsule; FA; fractional anisotropy; HCEP; Hockey Concussion Education Project; IC; internal capsule; ImPACT; Immediat
Keywords: urinary bladder neoplasms; hematuria; pathology; molecular; RNA; messenger; early detection of cancer; ABL1; ABL proto-oncogene 1; ANXA10; annexin 10; BCa; bladder cancer; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CRH; corticotropin releasin
Keywords: urinary bladder neoplasms; neoplasm invasiveness; neoplasm recurrence; local; BCG vaccine; mortality; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CR; complete response; DSS; disease specific survival; MIBC; muscle invasive bladder cancer; NMIB
Keywords: Liver surgery; Laparoscopy; Hospital stay; Complication; Meta-analysis; CRD42017058124; LH; laparoscopic hepatectomy; OH; open hepatectomy; RCTs; randomized controlled trials; CNKI; China National Knowledge Infrasture; ASA; American Society of Anesthesiol
Keywords: dB; A-weighted decibels; CIs; Confidence interval; OR; Odds ratio; RR; Relative risk; Environmental exposure; Noise exposure; Diabetes mellitus; Transportation noise; Traffic; Glucose homeostasis;
Keywords: MS; multiple sclerosis; MS-RR; relapsing-remitting multiple sclerosis; MS-SP; secondary progressive multiple sclerosis; MS-PP; primary progressive multiple sclerosis; IFN-Ã; interferon-beta; GA; glatiramer acetate; DMT; disease-modifying treatment; CIS;
Keywords: α-CGRP; alpha-calcitonin gene related peptide; Ang; angiopoietin; AE2; anion exchanger 2; ADP; adenosine diphosphate; ADPKD; autosomal dominant polycystic kidney disease; ATP; adenosine triphosphate; ASBT; sodium-dependent bile acid transporter; AQP; aqu
Keywords: AD; axial diffusivity; AUC; area under the curve; CIS; clinically isolated syndrome; CON; Contrack; CSD; constrained spherical deconvolution; DTI; diffusion tensor imaging; DWI; diffusion weighted imaging; DW-MRI; diffusion weighted magnetic resonance ima
Keywords: a-Si; Amorphous silicon; BNetzA; Federal Network Agency for Electricity; CdTe; Cadmium telluride; CF; Cash Flow; CIS; Copper indium diselenide; CNT; Carbon nanotubes; CPV; Concentrating photovoltaics; c-Si; Crystalline silicon; EU; European Union; Eurosta
Keywords: CI; cochlear implant; HA; hearing aid; PTA; pre-implant pure-tone average; PTS_CI; post-implant pure-tone average; SPEAK; spectral peak; ACE; advanced combination encoder; CIS; continuous interleaved sampling; MPS; multiple pulsatile sampler; ANOVA; analy
Keywords: CIS; cerebral ischemic stroke; MSCs; mesenchymal stem cells; GVHD; graft-versus host reaction; BDNF; brain-derived neurotrophic factor; NGF; nerve growth factor; FGF; fibroblast growth factor; VEGF; vascular endothelial growth factor; Evs; extracellular v
Keywords: AIS; acute immobilization stress; BDNF; brain-derived neurotrophic factor; BSA; bovine serum albumin; CIS; chronic immobilization stress; CRF; corticotropin-releasing factor; CRFR1; corticotropin-releasing factor receptor 1; DG; dentate gyrus; DOR; delta
Keywords: Esophageal Cancer; Genomics; Epigenomics; ADAR; adenosine deaminases acting on RNA; APOBEC; apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like; BCH; basal cell hyperplasia; CIS; carcinoma in situ; CNA; copy number alteration; ESCC; esophagea
Keywords: a-Si; amorphous silicon; BIPV; building integrated photovoltaic; BOS; balance of system; CdTe; cadmium telluride thin film; CIS; copper indium selenide thin film; DSSC; dye sensitized solar cell; EG-silicon; electronic silicon; EPBT; energy payback time;
Keywords: Esophageal Cancer; Imaging; Early Detection; Accuracy; CIS; carcinoma in situ; ESCC; esophageal squamous cell carcinoma; ESD; esophageal squamous dysplasia; ESECC; esophageal cancer screening in China; EVL; endoscopically visualized lesion; NEVL; not endo
Keywords: Demyelination; Multiple sclerosis; Pediatric; Incidental findings; ADEM; acute disseminated encephalomyelitis; CIS; clinically isolated syndrome; CNS; central nervous system; DIS; dissemination in space; DIT; dissemination in time; DMT; disease modifying
Keywords: ALDH; aldehyde dehydrogenase; CSCs; cancer stem cells; Cis; cisplatin; DEAB; N,N-diethylaminobenzaldehyde; DCFAB; 2â²,7â²-dichlorofluorescin diacetate; Dox; doxorubicin; DSBs; DNA double strand breaks; DLL4; delta-like 4; EGF; epidermal growth factor; E
Keywords: 1G; First generation; 2G; Second generation; 3G; Third generation; AM; Air Mass; AOI; Angle of Incidence; ARC; Anti-Reflective Coating; a-Si; Amorphous silicon; AtaMo; Atacama Module; CDEC; Economic Load Dispatch Center; CdTe; Cadmium Tellurium; CIGS; Cop
Keywords: BSGI; breast-specific gamma imaging; ER; estrogen receptor; PR; progesterone receptor; HER2; human epidermal growth factor receptor 2; CIS; carcinoma in situ; EIC; extensive intraductal component; Breast; Neoplasms; Radionuclide imaging; Mammography; Path
Keywords: Quality of life; Patient care management; Patient reported outcomes; EQ5D; Registries; Regression analysis; AIC; Aikake's Information Criterion; CIS; Clinically Isolated Syndrome; DMT; Disease-modifying Therapy; EDSS; Expanded Disability Status Scale; EQ-
Keywords: Ag+-HPLC; silver-ion high performance liquid chromatography; ALA; α-linolenic acid (c9c12c15C18:3); BH; biohydrogenation; BI; biohydrogenation intermediates; BH_ALA; α-linolenic acid biohydrogenation index; BH_LA; linoleic acid biohydrogenation index; c
Keywords: TGCTs; testicular germ cell tumors; GCNIS; germ cell neoplasia in situ; ESCs; embryonic stem cells; ECCs; embryonal carcinoma cells; PGCs; primordial germ cells; IGCNU; Intratubular germ cell neoplasia of the unclassified type; CIS; Carcinoma in Situ; hPG
Keywords: Dietary sodium; Obesity; Central obesity; Body fat mass; Body lean mass; ASMI; Appendicular Skeletal Muscle Index; BMI; body mass index; CIs; confidence intervals; CVD; cardiovascular disease; DXA; dual-energy x-ray absorptiometry; NHANES; The National He
Keywords: MS; multiple sclerosis; CIS; clinically isolated syndrome; MRI; magnetic resonance imaging; DTI; diffusion tensor imaging; PASAT; paced auditory serial attention test; EDSS; expanded disability status scale; MMSE; mini-mental state examination; Multiple s
Keywords: GC/MS; Deconvolution; MS subtraction; Target/nontarget; Climate effects; Tea quality; MS; mass spectral; GC-GC/MS; 2-dimensional automated sequential gas chromatography/mass spectrometry; VOCs; volatile organic compounds; GC/MS; gas chromatography/mass sp
Keywords: AHR; aryl hydrocarbon receptor; BBB; blood-brain barrier; CNS; central nervous system; CIS; clinically isolated syndrome; EDSS; expanded disability status scale; EAE; experimental autoimmune encephalomyelitis; DC; dendritic cell; DMF; dimethyl fumarate; D
Keywords: Ginger; Multiple sclerosis; Experimental autoimmune encephalomyelitis; Therapeutic potentials; AP-1; Activator protein 1; APCs; Antigen-presenting cells; ASC; apoptosis speck-like protein containing CARD; BAFF; B cell-activating factor belonging to the TN
Keywords: CIS; carcinoma in situ; MIBC; muscle-invasive bladder cancer; NMIBC; non-muscle-invasive bladder cancer; RC; radical cystectomy; TURBT; transurethral resection of bladder tumour; Bladder cancer; TURBT; T1G3;
Keywords: CHI3L1; chitinase 3-like 1; MS; multiple sclerosis; RRMS; relapsing-remitting multiple sclerosis; CIS; clinically isolated syndrome; DMT; disease modifying therapies; IFNβ; interferon-beta; GA; glatiramer acetate; Chitinase 3-like 1; Interferon-beta; Gla
Keywords: Peripheral arterial disease (PAD); Alcohol intoxication; Population-based cohort; CIs; confidence interval; ICD-9-CM; International Classification of Diseases, Ninth Revision, Clinical Modification; HR; hazard ratio; LHID 2000; Longitudinal Health Insuran
Keywords: ALT; alanine aminotransferase; ANOVA; one-way analysis of variance; AST; aspartate aminotransferase; BMI; body mass index; BUN; blood urea nitrogen; CIs; confidence intervals; Cr; creatinine; CRP; C-reactive protein; DBP; diastolic blood pressure; FPG; fa
Keywords: CIs; confidence intervals; EIA; enzyme immunoassay; GMT; geometric mean titer; KCDC; Korea Centers for Disease Control and Prevention; KNHANES; Korea National Health and Nutrition Examination Survey; MCV; measles-containing vaccine; MMR; measles, mumps, a
Keywords: BREATHE; BRain dEvelopment and Air polluTion ultrafine particles in scHool children; CIs; Confidence intervals; OR; Odds ratio; OLI; Operational Land Imager; NDVI; Normalized Difference Vegetation Index; SES; Socioeconomic status; TIRS; Thermal Infrared S
Keywords: Children; Cross-reactivity; Drug hypersensitivity; Non-steroidal anti-inflammatory drugs; Selective responders; NSAID; Nonsteroidal anti-inflammatory drugs; CIs; cross-intolerants; SRs; selective responders; ENDA; European Network for drug Allergy; DPT; d
Keywords: AAPs; atypical antipsychotics; AOR; adjustedodds ratio; BD; bipolar disorder; CCI; Charlson comorbidity index; CIs; confidence intervals; ICD-9-CM; International Classification of Diseases, 9th Revision, Clinical Modification; IFN-γ; interferon-gamma; IL
Keywords: CIS; carcinoma in situ; RNU; radical nephroureterectomy; UTUC; upper tract urothelial carcinoma; Urological neoplasms; Transitional cell carcinoma; Ureteric neoplasms; Urinary bladder neoplasms; Intravesical recurrence;
Keywords: AO; aorta; ASA; American Society of Anesthesiologists; BMI; body mass index; CI; confidence interval; CIS; carcinoma in situ; CRTx; chemoradiotherapy; CT; computed tomography; CTx; chemotherapy; GEJ; gastroesophageal junction; GT; gastric tube; HH; hiatal
Keywords: OHCA; out-of-hospital cardiac arrest; BCPR; bystander cardiopulmonary resuscitation; EMS; emergency medical services; CPR; cardiopulmonary resuscitation; BLS; basic life support; SES; socioeconomic status; CDC; Centres for Disease Control and Prevention;
Keywords: BMI; body mass index; CIS; carcinoma in situ; CRP; C-reactive protein; CSS; cancer-specific survival; DSNB; dynamic sentinel node biopsy; EAU; European Association of Urology; HPV; human papillomavirus; ILND; inguinal lymph node dissection; IQR; interquar